A routine feasible HPLC analysis for the anti-angiogenic tyrosine kinase inhibitor, sunitinib, and its main metabolite, SU12662, in plasma

スポンサーリンク

概要

• 論文の詳細を見る
• 2009-11-01

著者

• Milano Gerard

  Oncopharmacology Unit Centre Antoine Lacassagne

• Etienne-grimaldi Marie-christine

  Oncopharmacology Unit Centre Antoine Lacassagne

• RENEE Nicole

  Oncopharmacology Unit, Centre Antoine Lacassagne

• IZZEDINE Hassan

  Medical Oncology Department, Hopital de la Pitie-Salpetriere

• Izzedine Hassan

  Medical Oncology Department Hopital De La Pitie-salpetriere

• Renee Nicole

  Oncopharmacology Unit Centre Antoine Lacassagne

関連論文

• A routine feasible HPLC analysis for the anti-angiogenic tyrosine kinase inhibitor, sunitinib, and its main metabolite, SU12662, in plasma
• Optimized blood sampling with cytidine deaminase inhibitor for improved analysis of capecitabine metabolites

スポンサーリンク